Pangenomic Health Inc. NARA
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -132.20% | 0.98% | 10.77% | 4.73% | 51.75% |
| Total Depreciation and Amortization | -77.78% | -90.00% | -93.55% | -95.24% | -80.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 793.99% | -32.12% | -51.50% | -65.70% | -89.72% |
| Change in Net Operating Assets | -118.58% | -94.00% | -75.06% | 19.45% | 71.78% |
| Cash from Operations | -928.93% | -1,726.47% | -3,159.57% | -353.72% | 57.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 164.00% | 344.36% | 282.98% | -51.30% | -63.34% |
| Total Debt Repaid | 182.24% | -- | -- | -269.07% | -156.36% |
| Issuance of Common Stock | 1,782.05% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 102.33% | -- | -- | 200.00% | -437.50% |
| Cash from Financing | 965.29% | 2,282.36% | 3,952.48% | 347.38% | -60.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 141.18% | 254.10% | 466.67% | 208.80% | -148.57% |